• 549 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

My primary interests are in developing novel therapeutic combinations for the treatment of gastrointestinal cancers. I am interested in incorporating immunotherapy and molecular testing into clinical trials.

Training Experience

2009Residency, St. Vincents Hospital, Melbourne Australia
2011Residency, University Hospitals Case Medical Center, Cleveland OH
2014Fellowship, University of Pittsburgh Medical Center
2014Fellowship, Northwestern University

Education/Academic qualification

MBBS, Flinders University of South Australia, Australia

… → 2005

Research interests

  • Cancer Biology
  • Colon / Rectal Cancer
  • Nanotechnology
  • Pancreatic Cancer

Fingerprint Dive into the research topics where Aparna Kalyan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Biliary Tract Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Fibroblast Growth Factor Receptors Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2015 2021

Research Output 2014 2019

  • 549 Citations
  • 15 Article
  • 7 Review article
  • 3 Comment/debate
  • 1 Editorial

A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation

Kamath, S. D., Lin, X. & Kalyan, A., Feb 2019, In : Oncologist. 24, 2, p. 151-156 6 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms

First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody–Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer

Kim, S. B., Meric-Bernstam, F., Kalyan, A., Babich, A., Liu, R., Tanigawa, T., Sommer, A., Osada, M., Reetz, F., Laurent, D., Wittemer-Rump, S. & Berlin, J., Oct 1 2019, In : Targeted Oncology. 14, 5, p. 591-601 11 p.

Research output: Contribution to journalArticle

Open Access
Receptor, Fibroblast Growth Factor, Type 2
Maximum Tolerated Dose
2 Citations (Scopus)

Piloting a financial counseling intervention for patients with cancer receiving chemotherapy

Kircher, S. M., Yarber, J., Rutsohn, J., Guevara, Y., Lyleroehr, M., Jackson, H. A., Walradt, J., Desai, B., Mulcahy, M. F., Kalyan, A., Benson III, A. B., Agulnik, M., Mohindra, N. A., DeSouza, J. & Garcia, S. F., Mar 1 2019, In : Journal of oncology practice. 15, 3, p. E202-E210

Research output: Contribution to journalArticle

Drug Therapy
Costs and Cost Analysis
1 Citation (Scopus)

Pembrolizumab for the treatment of gastric cancer

Kamath, S. D., Kalyan, A. & Benson, A. B., Dec 2 2018, In : Expert review of anticancer therapy. 18, 12, p. 1177-1187 11 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
25 Citations (Scopus)

Updates on immunotherapy for colorectal cancer

Kalyan, A., Kircher, S., Shah, H., Mulcahy, M. & Benson, A., Feb 1 2018, In : Journal of Gastrointestinal Oncology. 9, 1, p. 160-169 10 p.

Research output: Contribution to journalReview article

Colorectal Neoplasms
Active Immunotherapy
Standard of Care
Microsatellite Repeats